Tag Archives: TMUS

Top 10 Low Price Stocks To Buy For 2019

A few weeks ago, we published an article that characterized Gilead (GILD) as a “Value Trap.” That article was a follow-up to an earlier article which used our work on Gilead as an example of how a solid conceptual framework could help investors make better decisions. Both of these articles were based on a 16-page valuation report on Gilead we published to our members in September, 2016.

We caught a lot of flack for the recent characterization of Gilead as a value trap, but our opinion was redeemed on February 7th, when the stock fell heavily after a disappointing earnings announcement.

In today’s article, we’ll take another look at the valuation process – the most important weapon in an investor’s arsenal – in a continuation of the Gilead example. We would invite new readers to read through each of the earlier articles as well, to get a picture of the overall process!

Investing Anecdotes are Dangerous!

What interested us in September 2016, when we made our original analysis of Gilead, was the noise among the value investing community about what a deal Gilead was because the stock was trading at such a low Price-to-Earnings (P/E) ratio (See our article Three Things You Should Know About Gilead).

Top 10 Low Price Stocks To Buy For 2019: USG Corporation(USG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    USG Co. (NYSE:USG) – Equities research analysts at SunTrust Banks reduced their Q3 2018 earnings per share estimates for shares of USG in a report issued on Monday, July 9th. SunTrust Banks analyst K. Hughes now forecasts that the construction company will post earnings of $0.57 per share for the quarter, down from their previous estimate of $0.61. SunTrust Banks currently has a “Hold” rating and a $44.00 price target on the stock. SunTrust Banks also issued estimates for USG’s FY2018 earnings at $2.05 EPS, Q3 2019 earnings at $0.71 EPS and FY2019 earnings at $2.53 EPS.

  • [By Stephan Byrd]

    ValuEngine upgraded shares of USG (NYSE:USG) from a buy rating to a strong-buy rating in a report published on Tuesday.

    A number of other research analysts have also recently weighed in on the stock. Credit Suisse Group upgraded shares of USG from an underperform rating to a neutral rating and dropped their target price for the company from $35.00 to $24.00 in a research note on Friday, April 27th. Jefferies Group reiterated a hold rating and issued a $40.00 target price on shares of USG in a research note on Monday, April 23rd. SunTrust Banks boosted their target price on shares of USG from $42.00 to $44.00 and gave the company a hold rating in a research note on Tuesday, April 17th. Buckingham Research boosted their target price on shares of USG from $34.00 to $42.00 and gave the company a neutral rating in a research note on Monday, April 16th. Finally, Nomura boosted their target price on shares of USG from $39.00 to $44.00 and gave the company a neutral rating in a research note on Tuesday, March 27th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $39.00.

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By Jordan Wathen]

    As USG Corporation (NYSE:USG) drags its feet on an offer to sell the company for $42 per share, Berkshire intends to use its 30.8% ownership stake to motivate its top brass to make a deal. Berkshire told Bloomberg it intends to vote its shares against USG’s board members who are up for re-election at this year’s annual meeting, a clear message that Buffett is ready to cash in, even if USG’s management and board are not.

  • [By Dan Caplinger]

    Warren Buffett likes to hold his stock positions for the long run, and his experience with USG (NYSE:USG) has been typical of his other long-term investments. The Oracle of Omaha started buying shares of the manufacturer of Sheetrock drywall and other building materials back in 2000, accumulating a sizable stake that has ballooned to more than 30% of the company. USG ended up going through bankruptcy in order to get a handle on its asbestos liability claims, but thanks largely to Buffett’s involvement, the building materials company not only survived bankruptcy but also saw share prices soar briefly on hopes that USG would once again fully participate in the then-strong housing boom.

Top 10 Low Price Stocks To Buy For 2019: Tekla Healthcare Opportunies Fund(THQ)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Tekla Healthcare Opportunities Fund (NYSE:THQ) declared a monthly dividend on Monday, June 11th, Wall Street Journal reports. Investors of record on Wednesday, June 20th will be paid a dividend of 0.1125 per share on Friday, June 29th. This represents a $1.35 dividend on an annualized basis and a dividend yield of 7.72%. The ex-dividend date of this dividend is Tuesday, June 19th.

Top 10 Low Price Stocks To Buy For 2019: Ampco-Pittsburgh Corporation(AP)

Advisors’ Opinion:

  • [By ]

    New York (AP) — Four more deaths have been linked to a national food poisoning outbreak blamed on tainted lettuce, bringing the total to five.

    Health officials have tied the E. coli outbreak to romaine lettuce grown in Yuma, Arizona. The growing season there ended six weeks ago, and it's unlikely any tainted lettuce is still in stores or people's homes, given its short shelf life. But there can be a lag in reporting, and reports of illnesses have continued to come in.

  • [By ]

    Cayce, S.C. (AP) — A crash between an Amtrak passenger train and a CSX freight train in South Carolina has left at least two people dead and more than 50 injured

  • [By ]

    Wellington, New Zealand (AP) — New Zealand plans to slaughter about 150,000 cows as it tries to eradicate a strain of disease-causing bacteria from the national herd.

  • [By Shane Hupp]

    Deutsche Bank AG boosted its holdings in Ampco-Pittsburgh Corp (NYSE:AP) by 117.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 19,599 shares of the industrial products company’s stock after purchasing an additional 10,578 shares during the quarter. Deutsche Bank AG’s holdings in Ampco-Pittsburgh were worth $242,000 at the end of the most recent quarter.

  • [By ]

    Phoenix (AP) — The classified advertising site Backpage.com ignored warnings to stop running advertisements promoting prostitution, sometimes involving children, because the lucrative enterprise brought in half a billion dollars, according to an indictment unsealed Monday.

Top 10 Low Price Stocks To Buy For 2019: BGC Partners, Inc.(BGCP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on BGC Partners (BGCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    DEUTSCHE BOERSE/ADR (OTCMKTS: DBOEY) and BGC Partners (NASDAQ:BGCP) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

  • [By ]

    BGC Partners (BGCP) : “We’re in a market where Goldman Sachs (GS) got slammed. I’m going with them.”

    Ecolab (ECL) : “That’s a terrific situation that I want you to buy more of if it comes down.”

  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Logan Wallace]

    LPL Financial (NASDAQ: LPLA) and BGC Partners (NASDAQ:BGCP) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

  • [By Ethan Ryder]

    UBS Group AG raised its holdings in shares of BGC Partners, Inc. (NASDAQ:BGCP) by 248.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,519,131 shares of the financial services provider’s stock after purchasing an additional 1,082,829 shares during the quarter. UBS Group AG’s holdings in BGC Partners were worth $20,432,000 as of its most recent SEC filing.

Top 10 Low Price Stocks To Buy For 2019: The York Water Company(YORW)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of York Water (NASDAQ:YORW) from a hold rating to a sell rating in a research report report published on Thursday.

    Separately, Hilliard Lyons raised shares of York Water from an underperform rating to a neutral rating in a research report on Thursday, March 8th.

Top 10 Low Price Stocks To Buy For 2019: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Brian Orelli]

    On Friday evening, bluebird bio (NASDAQ:BLUE) and Celgene (NASDAQ:CELG) will kick things off with their BCMA-targeted CAR T, bb2121, for patients with multiple myeloma who have failed other treatments. The results from the phase I trial have been impressive so far, albeit in a limited number of patients. The new data should include the expansion cohort of patient treated at the dose to be used in later-stage trials.

  • [By Stephan Byrd]

    bluebird bio (NASDAQ:BLUE) was up 0% during mid-day trading on Thursday . The stock traded as high as $190.50 and last traded at $189.30. Approximately 892,250 shares traded hands during mid-day trading, an increase of 14% from the average daily volume of 779,838 shares. The stock had previously closed at $189.30.

  • [By Ethan Ryder]

    Blue Protocol (CURRENCY:BLUE) traded 5.2% lower against the US dollar during the one day period ending at 18:00 PM ET on June 27th. In the last seven days, Blue Protocol has traded down 29.4% against the US dollar. Blue Protocol has a total market capitalization of $3.16 million and approximately $3,034.00 worth of Blue Protocol was traded on exchanges in the last 24 hours. One Blue Protocol token can currently be bought for approximately $0.0862 or 0.00001406 BTC on exchanges including IDEX, YoBit, CoinExchange and EtherDelta (ForkDelta).

  • [By Motley Fool Staff]

    In his fourth segment — something blue — he talks about clinical-stage gene-therapy company bluebird bio(NASDAQ:BLUE). It’s a RuleBreakers recommendation, and it has been for almost three and a half years. It’s also a fine illustration of some key Foolish principles of investing.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Brian Orelli]

    bluebird bio (NASDAQ:BLUE) reportedfirst-quarter earnings last week, but like the biotech typically does, management didn’t hold a conference call, which makes the earnings release more of a rehash of the quarter than an actual update.

Top 10 Low Price Stocks To Buy For 2019: Cabot Corporation(CBT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Scopus Asset Management L.P. lifted its position in shares of Cabot Corp (NYSE:CBT) by 74.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 435,000 shares of the specialty chemicals company’s stock after buying an additional 185,000 shares during the quarter. Scopus Asset Management L.P.’s holdings in Cabot were worth $24,238,000 at the end of the most recent quarter.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
    International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
    Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
    General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
    Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
    Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
    Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
    National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
    The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
    Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
    AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
    Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
    Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
    Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39

  • [By Joseph Griffin]

    Sei Investments Co. increased its position in shares of Cabot Corp (NYSE:CBT) by 137.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,527 shares of the specialty chemicals company’s stock after acquiring an additional 40,219 shares during the quarter. Sei Investments Co. owned approximately 0.11% of Cabot worth $3,874,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Low Price Stocks To Buy For 2019: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Adam Levy]

    AT&T hopes its bundle can differentiate its product from competitors like Verizon (NYSE:VZ) and T-Mobile (NASDAQ:TMUS), and improve its customer retention. But as it adds more options to the bundle, it could deteriorate its margins without providing meaningful value to many customers.

  • [By ]

    Over on Real Money, Cramer talks about how to trade the highly unlikely deal between Sprint (S) and T-Mobile (TMUS) . Get more of his insights with a free trial subscription to Real Money.

  • [By Paul Ausick]

    The margins for wireless carriers have frayed as Sprint Corp. (NYSE: S), T-Mobile US Inc. (NASDAQ: TMUS), Verizon Communications Inc. (NYSE: VZ) and AT&T play for position among customers in a saturated market. The iPhone 8 still gives them a chance to go after one another with a new chess piece.

  • [By Daniel B. Kline]

    While Sprint (NYSE:S) has an all-stock deal in place to merge with T-Mobile (NASDAQ:TMUS), there are significant doubts that federal regulators will approve it. If that happens, T-Mobile will go back to its fight against Verizon (NYSE:VZ) and AT&T (NYSE:T), with perhaps some added maverick credibility.

Top 10 Low Price Stocks To Buy For 2019: Bovie Medical Corporation(BVX)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Ethan Ryder]

    TheStreet upgraded shares of Bovie Medical (NYSEAMERICAN:BVX) from a d rating to a c- rating in a research report report published on Monday morning.

  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o

Top 10 Low Price Stocks To Buy For 2019: Gladstone Commercial Corporation(GOOD)

Advisors’ Opinion:

  • [By Max Byerly]

    Goodomy (GOOD) is a PoW/PoS token that uses the Scrypt hashing algorithm. Its genesis date was June 21st, 2017. Goodomy’s total supply is 888,000,000 tokens and its circulating supply is 620,508,777 tokens. Goodomy’s official Twitter account is @GoodKarmaCoin and its Facebook page is accessible here. Goodomy’s official website is goodomy.com.

  • [By Shane Hupp]

    Goodomy (GOOD) is a PoW/PoS token that uses the Scrypt hashing algorithm. Its launch date was June 21st, 2017. Goodomy’s total supply is 888,000,000 tokens and its circulating supply is 620,508,777 tokens. Goodomy’s official Twitter account is @GoodKarmaCoin and its Facebook page is accessible here. Goodomy’s official website is goodomy.com.

Top 10 Blue Chip Stocks To Invest In 2018

Shutterstock

Dont take any stated yields for granted these days! The financial news has been flooded with dividend cuts lately, with Teva Pharmaceutical (TEVA) and Mattel (MAT) taking the hatchet to their payouts, and telecom Windstream (WIN) dropping its dividend too.

Its dangerous to buy headline yields or even supposedly safe blue chips with more modest dividends without looking at the profits funding these payouts. Companies with high payout ratios (how much in earnings, funds from operations and other measures a company pays out in the form of dividends) are a twofold risk:

High payout ratios can lead to a slowing in dividend growth, which means your payout is increasingly likely to fall behind inflation.

Top 10 Blue Chip Stocks To Invest In 2018: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    T-Mobile’s (NASDAQ:TMUS) aggressive pursuit of growth over the past few years has already been paying off, but Verizon Communications'(NYSE:VZ)earnings report this morning showing that it lost retail customers for the first time represents an important inflection point in the U.S. wireless industry. While T-Mobile has been poaching customers from all other carriers for years, the dominant domestic wireless carrier has held up relatively well despite intensifying competition — until now.

  • [By Craig Jones]

    On CNBC's Fast Money Halftime Report, Jon Najarian spoke about unusually high options activity in Home Depot Inc (NYSE: HD) and T-Mobile US Inc (NASDAQ: TMUS).

  • [By The Ticker Tape]

    Analysts at Raymond James think smartphone sell-through weakened in the U.S. in the past quarter, which matches softer demand reported in recent earnings from Verizon Communications Inc. (NYSE: VZ), AT&T Inc. (NYSE: T) and T-Mobile US Inc (NASDAQ: TMUS). Later this year, the company is expected to launch a new version of its iPhone.  

  • [By Douglas A. McIntyre]

    One of the notable things about the mall is the number of troubled retailers it houses. Long term, this may be bad for the mall’s finances. Macy’s, Abercrombie & Fitch Co. (NYSE: ANF), GameStop Corp. (NYSE: GME) and Gap Inc. (NYSE: GPS) have locations. However, Mall of America has buttressed its tenant list with scores of restaurants and with retailers like Apple Inc. (NASDAQ: AAPL), Microsoft Corp. (NASDAQ: MSFT) and T-Mobile US Inc. (NASDAQ: TMUS), which have very well-financed parents.

Top 10 Blue Chip Stocks To Invest In 2018: MGM Resorts International(MGM)

Advisors’ Opinion:

  • [By Craig Jones]

    Jon Najarian noticed some call options activity in MGM Resorts International (NYSE: MGM). Traders were buying the September 32/37 call spread in the first half of the session on Thursday. Najarian likes the trade and he decided to initiate a long position in MGM Resorts.

  • [By Ben Levisohn]

    Wynn wasn’t the only Macau casino operator that took it on the chin today. Las Vegas Sands (LVS) tumbled 13% to $54.67, while Melco Crown Entertainment (MPEL) plunged 14% to $16.87, and MGM Resorts International (MGM) dropped 4.3% to $28.65.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Jon C. Ogg]

    MGM Resorts International (NYSE: MGM) is also a top pick for the first quarter, and Merrill Lynch’s price objective of $33.00 was versus a recent price of $28.50. The consensus analyst target price is a tad higher at $33.86.

  • [By Ben Levisohn]

    With companies like Under Armour (UAA), MGM Resorts International (MGM), andUnited Parcel Service (UPS) reporting tomorrow, we thought we’d get a jump start on the stocks moving after today’s close:

Top 10 Blue Chip Stocks To Invest In 2018: Knight Transportation, Inc.(KNX)

Advisors’ Opinion:

  • [By Rich Smith]

    Knight Transportation (NYSE:KNX) is merging with Swift Transportation (NYSE:SWFT) to build a $5 billion trucking behemoth — and Wall Street thinks that’s a good thing.

Top 10 Blue Chip Stocks To Invest In 2018: Kohl’s Corporation(KSS)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    One theme that’s become apparent is that consumers are betting that a Trump tax cut will lead to more money in their pockets. That’s good news for the so-called “trade-up” stocks like Nordstrom (JWN) and Kohl’s (KSS) .

  • [By Craig Jones]

    Jon Najarian noticed that options traders were buying out of the money puts in Kohl's Corporation (NYSE: KSS). The company is going to report earnings on August 10 and it seems that traders believe the stock is going to continue to trade lower.

  • [By WWW.THESTREET.COM]

    The Bad

    Bonds behaved poorly. The 10 year and long bond rose by between 3-4 basis points in yield. I bought a trading position in iShares Barclays 20+ Yr Treas.Bond ETF (TLT) in front of a possible yearend pension rebalance. Big pharma stinks up the joint, again. Spec biotech is weakening again (Portola Pharmaceuticals PTLA, ACADIA Pharmaceuticals ACAD, etc.) Retail cant get out of its way. I am long JC Penney (JCP) and have trading positions in Kohl’s (KSS) and Macy’s (M) . (Nike (NKE) , Nordstrom (JWN) , Lowe’s (LOW) are downside features).

    The Ugly

  • [By Ben Levisohn]

    By now, we all know retailers are facing a tough time. More and more, people are choosing to shop online, putting sales under pressure and leaving many with too many stores. Some department stores have begun to acknowledge the problems–but will they be able to adjust quickly enough in a rapidly changing landscape? Credit Suisse analyst Christian Bussand team believe this process is “well under way” but that didn’t stop them from downgrading Kohl’s (KSS) and J.C. Penney (JCP), even as they upgraded Nordstrom (JWN) and Burlington Stores(BURL). They explain why:

  • [By Ben Levisohn]

    Kohl’s (KSS) tumbled to the bottom of the S&P 500 today after offering earnings guidance that was well below analyst forecasts.

    Getty Images

    Kohl’sdropped 19% to $42.01 today, while the S&P 500 dipped 0.1% to 2,269.00.

    RBC’s Brian Tunick and Bilun Boyner worry that the bear case gas been revived:

    Kohl’s reported Holiday comps of -2%, below our model for -0.5%, as sales remained volatile through the quarter. Similar to early commentary by peers, stronger sales for Black Friday and the week before Christmas were offset by softness in early November and December. In line with Q3, the strongest categories were men’s, home, and footwear while accessories was most challenging.

    In addition to the sales downside,Kohl’s lowered its EPS guidance to $3.603.65 (from $3.804.00) to reflect lower than expected gross margins (we estimate were down 5060bps versus our prior model for up 40bp), which was mainly due to mix, timing of sales, and promotional environment as the company worked to exit the year with clean inventory positions (planning to end the year with inventories down mid-to-high SD)…

    AlthoughKohl’s still has a reasonable 1H’17 opportunity with easy gross margin compares, Under Armour (UA) launch, and potential for a new CFO, we believe disappointing Holiday sales and the guidance cut removed most of the market’s excitement around a return to momentum, reviving the secular bear case around department stores and Kohl’s. Maintaining Underperform and lowering price target to $42.

    Kohl’s market capitalization fell to $7.7 billion today from $9.2 billion yesterday. It reported net income of $673 million on sales of $19 billion in 2016.

Top 10 Blue Chip Stocks To Invest In 2018: Allegheny Technologies Incorporated(ATI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday morning, the basic materials shares climbed by 0.95 percent. Meanwhile, top gainers in the sector included Allegheny Technologies Incorporated (NYSE: ATI), up 5 percent, and Mechel PAO (ADR) (NYSE: MTL), up 5 percent.

  • [By Dan Caplinger]

    The stock market performed well on Tuesday, responding to steady improvement among many companies as earnings season kicked into high gear. Although political issues are likely to remain in the spotlight for some investors for the foreseeable future, many market participants are looking to economic and business issues in driving their investing decisions. Major market benchmarks finished the day with gains of 0.5% to 1%, but some stocks did much better. Among the best performers on the day were Allegheny Technologies (NYSE:ATI), II-VI (NASDAQ:IIVI), and Beazer Homes (NYSE:BZH). Below, we’ll look more closely at these stocks to tell you why they did so well.

Top 10 Blue Chip Stocks To Invest In 2018: Renesola Ltd.(SOL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Wall Street expects ReneSola Ltd. (ADR) (NYSE: SOL) to report a quarterly loss at $0.04 per share on revenue of $256.05 million. ReneSola shares gained 2.50 percent to close at $1.23 on Friday.

  • [By Monica Gerson]

    ReneSola Ltd. (ADR) (NYSE: SOL) is estimated to report a quarterly loss at $0.04 per share on revenue of $256.05 million.

    America’s Car-Mart, Inc. (NASDAQ: CRMT) is projected to post its quarterly earnings at $0.58 per share on revenue of $149.13 million.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Monica Gerson]

    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 9.76 percent to $1.35 in pre-market trading. ReneSola reported Q1 earnings of $0.06 per share on revenue of $260.7 million.

Top 10 Blue Chip Stocks To Invest In 2018: Zillow Group, Inc.(Z)

Advisors’ Opinion:

  • [By Steve Symington]

    The stock market was mostly flat today ahead of a key House vote on the passage of the Republicans’ healthcare bill, which was delayed until Friday after GOP lawmakers failed to gather the necessary support. TheDow Jones Industrial Averagelost just 5 points, or 0.02%, while other broader market indexes saw similar small declines. But several individual stocks saw much more severe drops, including Zillow Group (NASDAQ:Z) (NASDAQ:ZG), Proofpoint (NASDAQ:PFPT), and Accenture (NYSE:ACN). Read on to see what drove these unusual moves.

  • [By Steve Symington]

    Shares of Zillow Group Inc. (NASDAQ:Z)(NASDAQ:ZG)climbed 13.8% in the month of April,according to data provided byS&P Global Market Intelligence, ahead of the online real estate specialist’s impending first-quarter 2017 report.

  • [By Nelson Hem]

    Also in this week’s Barron’s:

    A special report on strategic beta ETFs How to take advantage of underpriced stocks Who is in denial about the death of the personal computer market Finding the best value mutual funds Finding value in big stocks and emerging markets How mining companies are striving for sustainability Why Zillow Group, Inc.-Class C (NASDAQ: Z) could fall 25 percent Six unconventional yield plays for an uncertain market Why Alibaba Group Holding Ltd (NYSE: BABA) investors may lose in hot IPO

    Disclosure: At the time of this writing, the author had no position in the mentioned equities.

Top 10 Blue Chip Stocks To Invest In 2018: Catalyst Pharmaceuticals, Inc.(CPRX)

Advisors’ Opinion:

  • [By William Romov]

    Before we show you our pick, here are the top 10 penny stocks to watch this week

    Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
    Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
    Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
    Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
    Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
    UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
    WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
    PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
    Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
    EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
    Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free

  • [By Lisa Levin]

    Shares of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) got a boost, shooting up 32 percent to $1.54 after the company reported positive data from investigator-sponsored trial of Firdapse.

Top 10 Blue Chip Stocks To Invest In 2018: Quality Systems, Inc.(QSII)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Elite Opportunity Pronewsletter suggested small cap health care technology stock Quality Systems, Inc (NASDAQ: QSII) as a short-term trading opportunity after popping sharply on news:

Top 10 Blue Chip Stocks To Invest In 2018: News Corporation(NWS)

Advisors’ Opinion:

  • [By Monica Gerson]

    News Corp (NASDAQ: NWS) reported a profit of $506 million, or $0.87 per share for the year ended June 30, versus a year-ago loss of $2.08 billion, or $3.58 per share. Its revenue rose 2.7% to $8.89 billion. However, analysts were expecting earnings of $0.57 per share on revenue of $8.96 billion. News Corp shares fell 1.28% to close at $16.91 on Friday.

Tucows – Ting Is The Future!

Around four years ago, I heard about Ting through an ad on YouTube. I was curious and fascinated, but I did not take time to do a proper research about it. However, around two years ago, when I started investing, I began to constantly hear about Ting through several ads on YouTube and on podcasts. Therefore, today, since I am building my investment portfolio, I am very interested in Tucows Inc. (NYSEMKT:TCX), the owner of Ting.

Tucows (TSE:TC, NASDAQ:TCX) is an Internet services and telecommunications company, headquartered in Toronto, Ontario, Canada.

Tucows is organized and managed into two segments: Domain Services and Network Access Services.

Domain Services

The domain services are Tucows’ mature, legacy business that generates a recurring cash flow. Tucows is the second-largest domain registrar in the world, behind GoDaddy (NYSE:GDDY).

It is important to note that Tucows is a registrar, not a registry. A registrar earns revenues via registration fees. It charges resellers connecting with new, renewed, and transferred domain registration. It pays out a portion of the price it receives to the registry, Verisign (NASDAQ:VRSN) and ICANN, for each registered domain. Plus, with every renewal domain, it creates recurring revenue for all the parties involved.

Elliot Noss, the CEO of Tucows, explains the revenue model for the domain services in this YouTube video. Tucows has numerous excellent videos that explain different aspects of the company to current investors and potential investors. I strongly recommend to watch them.

Network Access Services

The network access services are Tucows’ growing business. The network access services are composed of two departments: Ting Mobile and Ting Internet.

Ting Mobile

Ting Mobile is a mobile virtual network operator (MVNO). It does not own the wireless infrastructure over which it provides services to customers. In fact, it leases the infrastructure from Sprint (NYSE:S) and T-Mobile (NASDAQ:TMUS).

Ting’s business model is different from other mobile network operators’ business model. It is a pay-as-you-go plan with no fixed contract. During recent years, Ting’s number of customers grew considerably due to three main reasons:

Ting’s customers have the best customer service; Ting’s customers save, on average, $23 per device monthly; Ting’s customers have a bill of $37 monthly, which is significantly lower than the usual bill.

It is important to know that around 11% of new customers are referred by current customers of Ting services.

Ting Internet

Ting Internet is different from Ting Mobile. Instead of leasing an infrastructure and providing services, Ting Internet builds an infrastructure to give fiber Internet to customers. Hence, it cannot provide fiber Internet across the United States. It can only give access to gigabit fiber Internet in Ting Towns, which are presently these three municipalities:

Holly Springs, North Carolina; Westminster, Maryland; Charlottesville; Virginia.

Ting is taking pre-orders to bring gigabit fiber Internet to Sandpoint, Idaho, and to Centennial, Colorado.

Source: Ting Internet

Ting Internet’s focus is to provide gigabit Internet to individuals and business customers. Just like Ting Mobile, its revenue is generated in the United States and provided on a monthly basis with no fixed contract term.

Opportunities

According to me, the most prominent opportunity for Tucows is Ting. As of September 2017, Ting has approximately 171,000 subscribers and 281,000 devices under management. Compared to the previous year, the number of subscribers has increased by 16.33%, and the number of devices has increased by 19.57%.

Number of subscribers and devices under management end of September 30

2017 2016

Ting mobile subscriber under management

171,000 147,000

Ting mobile devices under management

281,000 235,000

Source: Company 10-Q

Ting’s gross margin has also been increasing significantly. It is currently standing at approximately 50%.

Gross margin

Source: Company Presentation February 2017

Ting has received the highest overall rating in the history of the Consumer Report survey because it provides excellent services at low prices to their customers. Thus, I do not see any reason why Ting Mobile will not be able to attract more customers in the future. By continuing to deliver the same improved services, it will have a great recurring avenue. Moreover, Ting Mobile is one of the few MVNO that can provide iPhone an AppleCare. This is important for customers because it allows them to have everything in one place and it allows to have a better integration with the services, such as Visual Voicemail and WiFi calling.

As for Ting Internet, I believe it will most likely become the Internet leader in the Ting Towns where the population is relatively low. Hence, the big players will not be willing to build new infrastructures to provide Internet to the residents of these towns. The most important competitors of Ting Internet are the cable companies and the phone companies, but they are not able to give a speed similar to gigabyte Internet. Recently, Tucows has bid to buy Burlington Telecom, a publicly owned fiber network in Burlington, Vermont, for a price of $32 million. If the offer passes, Burlington will be the fourth Ting Town.

Management

Tucows CEO Elliot Noss has been running the business for more than 20 years. Even though he is not the founder, he is the biggest single shareholder. For the retail shareholder, this is a high vote of confidence that the CEO has significant stakes of his net worth in Tucows. Not only the CEO but also other leadership members have stakes in the company. In fact, according to Seeking Alpha, the inside ownership holds 24.27% of outstanding shares.

Risk

According to me, the most prominent risk for Tucows is the reliance on Sprint and T-Mobile for network access. In the future, both of the companies can decide no longer to allow Ting to use their infrastructure. This is unlikely to happen, but is still possible.

The legacy business, domain registration space, is mature and is becoming more competitive. Thus, I believe that it will be more challenging to grow the segment in the future.

Another risk for Tucows is the currency. The majority of Tucows’ revenue comes from the United States, but the operating cost is mostly in Canadian dollars.

My two cents

I believe Tucows is an excellent company with great potential for the future. I do not personally own Tucows in my portfolio. I think I will wait for a pullback to add a position in Tucows. If there is a decline in the market or a crisis, I will be able to become an owner for a lower price.

If you disagree with my thesis, please let me know in the comments. I believe it is the best way to understand a company and to learn new things.

If you liked this article and are interested to read my previous articles or my new article, a follow will be appreciated.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: Before investing in any companies, please do your own research.

About this article:ExpandAuthor payment: $35 + $0.01/page view. Authors of PRO articles receive a minimum guaranteed payment of $150-500.Tagged: Investing Ideas, Long Ideas, Technology, Internet Information Providers, CanadaWant to share your opinion on this article? Add a comment.Disagree with this article? Submit your own.To report a factual error in this article, click here

Dividend Monster AT&T Inc. Is Nearing Major Resistance

AT&T Inc. (NYSE:T) has been on fire, rallying over 15% since November 1. However, T stock price is still down more than 9% so far for 2017. So is it time to get in on this recent momentum or take a pass on the telecom giant?

Let’s look at the chart first.

Trading T Stock Price

AT&T certainly has positives, but its chart is anything but pretty. T stock price made a bullish move when it was able to reclaim the $35 mark. Above that and it was a reasonable long. However, now pushing into the $39 level, T stock enters some serious resistance.

Chart of T stock priceinvestorplace.com/wp-content/uploads/2017/12/T-768×574.png 768w, investorplace.com/wp-content/uploads/2017/12/T-40×30.png 40w, investorplace.com/wp-content/uploads/2017/12/T-200×150.png 200w, investorplace.com/wp-content/uploads/2017/12/T-400×300.png 400w, investorplace.com/wp-content/uploads/2017/12/T-116×87.png 116w, investorplace.com/wp-content/uploads/2017/12/T-100×75.png 100w, investorplace.com/wp-content/uploads/2017/12/T-167×125.png 167w, investorplace.com/wp-content/uploads/2017/12/T-67×50.png 67w, investorplace.com/wp-content/uploads/2017/12/T-78×58.png 78w, investorplace.com/wp-content/uploads/2017/12/T-800×598.png 800w,https://investorplace.com/wp-content/uploads/2017/12/T-160×120.png 160w, investorplace.com/wp-content/uploads/2017/12/T.png 900w” sizes=”(max-width: 300px) 100vw, 300px” />
Click to Enlarge

This isn’t a temporary level, either. This $39 to $40 region has been both support and resistance over the last 20 months or so. To get above it would be a huge win for the bulls. If traders are looking to add T stock to their portfolio now, it may be best to wait. I’d wait for AT&T to either pullback or break through this current level.

Further, you’ll see that the MACD (yellow circle) is nearing a points where, historically speaking, it tends to exhaust itself. Further, the Relative Strength Index (blue circle) is nearing an overbought state. T stock has approached $39 two other times since August with an RSI reading similar to its current levels. The odds favor a pullback or at the very least some consolidation.

The Fundamentals for T Stock

We recently took a look at who the holiday winners might be in the telecom space. Because Verizon Communications Inc. (NYSE:VZ) was strangely not offering a buy-one get-one (BOGO) deal for the new Apple Inc. (NASDAQ:AAPL) iPhone, AT&T and T-Mobile Us Inc (NASDAQ:TMUS) were the likely winners.

AT&T’s BOGO offer wasn’t quite as good at T-Mobile’s, but it was likely enough to still attract new subs. That should bode well for its fourth-quarter results. Let’s hope that’s the case, as expectations for 2017 aren’t that great. Presently, analysts expect sales to contract 2.2% this year before growing just 20 basis points in 2018.

While positive revenue growth forecasts for 2018 are an improvement, it comes at a cost. Earnings growth of 2.5% in 2017 will slip to just 0.3% in 2018. But no one is buying T stock for the earnings and revenue growth. If investors want that, it’s best to look at T-Mobile. (The story we linked to above sheds light as to why.)

Instead, it’s about a low valuation and fat dividend yield. In fact, just a few days ago, T stock increased its quarterly dividend by 2% to 50 cents per share. While 2% is a small bump, the move marks AT&T’s 34th consecutive year of a higher payout. That’s something that many income investors can hang their hat on. They can count on AT&T — which now pays out 5.2% — to continue paying out that dividend for years and years to come.

To make matters even better, T stock price trades at just 13 times 2018 earnings estimates. Despite its near-zero growth, this is a low valuation for such a big, dependable dividend yield.

Bottom Line on T Stock

Through the first nine months of fiscal 2017, AT&T has a free cash flow dividend payout ratio of 70.5%. This figure is up from 66.8% during the same period a year ago. It basically means that 70% of T’s free cash flow covers the dividend. On the plus side, T stock’s dividend is covered simply by the free cash flow generated by the business. On the downside, this figure is up almost 400 basis points year-over-year. This will widen even more with the recent dividend hike.

While that’s something to keep an eye one, so too is AT&T’s pending acquisition of Time Warner Inc (NYSE:TWX). Should the company lock in Time Warner, it will add a whole host of content and free cash flow to its current business. While the roughly $85 billion deal is a biggie, many believe it will be favorable to AT&T.

Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell. As of this writing, Bret Kenwell did not hold a position in any of the aforementioned securities.

 

Compare Brokers

Top 10 Medical Stocks To Watch For 2018

Gladstone, NJ, based Investment company Murphy Capital Management Inc buys SPDR Select Sector Fund – Consumer Discretionary, Bristol-Myers Squibb Company, SPDR Select Sector Fund – Industrial, Lear, OSI Systems, SPDR Select Sector Fund – Consumer Staples, Siemens AG, CBS, iShares MSCI Emerging Index Fund, FedEx, sells Xylem, Time Warner, St Jude Medical, Mead Johnson Nutrition Co, Becton, Dickinson and Co during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Murphy Capital Management Inc. As of 2017-03-31, Murphy Capital Management Inc owns 266 stocks with a total value of $660 million. These are the details of the buys and sells.

New Purchases: LEA, OSIS, CBS, FEZ, ACWI, ACIA, CNC, ETN, GLW, ADBE, Added Positions: XLY, BMY, XLI, XLP, SIEGY, AMZN, FB, EEM, FDX, FEU, Reduced Positions: AAPL, XYL, TWX, BDX, SBUX, HD, UPS, XLV, DIS, EL, Sold Out: STJ, MJN, JCI, GATX, GPC, BT, PX, TM, OKE, OTEX,

For the details of MURPHY CAPITAL MANAGEMENT INC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=MURPHY+CAPITAL+MANAGEMENT+INC

Top 10 Medical Stocks To Watch For 2018: iShares Core S&P Mid-Cap (IJH)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Lubar & Co., Inc’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Lubar+%26+Co.%2C+Inc

    These are the top 5 holdings of Lubar & Co., IncEnLink Midstream LLC (ENLC) – 1,882,007 shares, 37.97% of the total portfolio. Shares added by 0.40%Hallador Energy Co (HNRG) – 2,788,685 shares, 23.23% of the total portfolio. Vanguard Value ETF – DNQ (VTV) – 77,126 shares, 7.65% of the total portfolio. iShares Core S&P Mid-Cap (IJH) – 38,400 shares, 6.84% of the total portfolio. New PositionVanguard Mid-Cap Value ETF – DNQ (VOE) – 61,550 shares, 6.52% of the tota

Top 10 Medical Stocks To Watch For 2018: CRH Medical Corporation(CRHM)

Advisors’ Opinion:

  • [By Lisa Levin]

    CRH Medical Corp (NYSE: CRHM) was down, falling around 31 percent to $2.55 after the company disclosed financial and operating results for the quarter and six months ended June 30, 2017.

Top 10 Medical Stocks To Watch For 2018: 3M Company(MMM)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Who are the likely candidates for the next round of upgrades? Cramer said he’s betting that 3M (MMM) will be in the mix, along with Walmart (WMT) and especially Home Depot (HD) , which should have a strong spring planting season with good comparisons to last year. Investors might also see upgrades on Honeywell (HON) and Nike (NKE) , Cramer suggested.

  • [By Lisa Levin]

    3M Co (NYSE: MMM) agreed to sell substantially all of its communication markets division to Corning Incorporated (NYSE: GLW) for $900 million.

    Corning expects the deal adding $0.07 to $0.09 per share in FY19 earnings.

  • [By Shanthi Rexaline]

    Here is the list of the Dow components, which are scheduled to report this week:

    1. 3M Co
    Company: 3M Co (NYSE: MMM). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $2.54 versus $2.08. Revenue Estimate: $7.86 billion versus $7.66 billion. Stock Gain/Loss (year to date): 18.12 percent.
    2. Caterpillar
    Company: Caterpillar Inc. (NYSE: CAT). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.25 versus $1.09. Revenue Estimate: $10.93 billion versus $10.94 billion. Stock Gain/Loss (year to date): 16.10 percent.
    3. McDonald’s
    Company: McDonald’s Corporation (NYSE: MCD). Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.62 versus $1.45. Revenue Estimate: $5.96 billion versus $6.26 billion. Stock Gain/Loss (year to date): 25.35 percent.
    4. United Technologies
    Company: United Technologies Corporation (NYSE: UTX) Date of Reporting: Tuesday, before the market open. EPS Estimate vs. Year-ago EPS: $1.78 versus $1.82. Revenue Estimate: $15.24 billion versus $14.87 billion. Stock Gain/Loss (year to date): 12.47 percent.

    See also: 3 Reasons Alcoa Is No Longer The Curtain-Raising Event Of Earnings Season

Top 10 Medical Stocks To Watch For 2018: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ: APOP) shares were also up, gaining 135 percent to $7.79 after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.

  • [By Chris Lange]

    Cellect Biotechnology Ltd. (NASDAQ: APOP) reported that it received a formal notice from the U.S. Patent and Trademark Office (USPTO)regarding its method of treatment for immune related disorders. Basically, the USPTO gave a notice of allowance which broadly means the agency intends to issue a patent approval. The treatment method relates to the engineering of regulatory immune cells with enhanced apoptotic activity used for the treatment or prevention for the unmet needs seen in type 1 diabetes, inflammatory bowel disease, graft versus host disease, and transplant rejection.

Top 10 Medical Stocks To Watch For 2018: Unifi, Inc.(UFI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Unifi, Inc. (NYSE: UFI) shares were also up, gaining 18 percent to $26.92 as the company announced Q3 earnings of $0.56 per share on revenue of $161.3 million.

Top 10 Medical Stocks To Watch For 2018: Southern Company (The)(SO)

Advisors’ Opinion:

  • [By Ben Levisohn]

    For those that are looking to express a more downbeat market view, or looking for a source of funds, we can neutralize our positive S&P 500 outlook and aim to sell stocks that are at risk to underperform on a relative basis. While a rising tide lifts all boats in absolute terms, we found that mega-cap safety is the central theme linking stocks that are at, or nearing, decade-long relative lows vs. the S&P 500: General Electric, Southern (SO), Simon Property Group (SPG), Verizon Communications (VZ), Wal-Mart, ExxonMobil. We see such relative weakness as a sign of vulnerability in their trend.

  • [By ]

    Under a single-payer system, healthcare becomes a regulated utility much like electricity with just a few large, best-in-class players. Athenahealth (Nasdaq: ATHN) could combine with Walgreen Boots Alliance (NYSE: WBA). Maybe each monolith will cover a specific region like Southern Company (NYSE: SO) and Consolidated Edison (NYSE: ED).

  • [By WWW.MONEYSHOW.COM]

    Southern Company (SO) produces 44,000 megawatts of generating capacity and 1,500 billion cubic feet of combined natural gas consumption and throughput volume.

Top 10 Medical Stocks To Watch For 2018: MDC Partners Inc.(MDCA)

Advisors’ Opinion:

  • [By Lisa Levin]

    MDC Partners Inc (NASDAQ: MDCA) shares dropped 60 percent to $3.38. MDC Partners reported a Q3 loss of $0.64 per share on revenue of $349.3 million.

  • [By Lisa Levin]

    Shares of MDC Partners Inc (NASDAQ: MDCA) were down 31 percent to $12.52 after the company posted downbeat quarterly results and lowered its FY16 sales outlook.

Top 10 Medical Stocks To Watch For 2018: T-Mobile US, Inc.(TMUS)

Advisors’ Opinion:

  • [By Chris Lange]

    T-Mobile US, Inc. (NASDAQ: TMUS) reported first quarter financial results after markets closed Monday. The company said that it had $0.80 in diluted GAAP earnings per share (EPS) and $9.61 billion in revenue, versus consensus estimates from Thomson Reuters that called for $0.34 in EPS and $9.62 billion in revenue. The same period from last year had $0.56 in EPS and $8.6 billion in revenue.

  • [By WWW.THESTREET.COM]

    Donald Trump’s election has proved a boon for shareholders of Sprint (S) , on the premise that a Republican administration would be open to a merger of the carrier to T-Mobile USA (TMUS) . Regulators under Obama had pushed back against Sprint Chairman Masayoshi Son’s goal of combining the U.S.’s third- and fourth-largest carriers.

  • [By Money Morning Staff Reports]

    SoftBank also purchased telecom upstart Sprint Corp. (NYSE: S) in 2013. And it is considering deals with other communications giants, including Charter Communications Inc. (Nasdaq: CHTR) and T-Mobile U.S. Inc. (Nasdaq: TMUS)

Top 10 Medical Stocks To Watch For 2018: Affimed N.V.(AFMD)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares rose 47.1 percent to $3.22 in pre-market trading after jumping 54.23 percent on Wednesday.
    Digital Power Corporation (NYSE: DPW) rose 27.6 percent to $0.800 in pre-market trading after gaining 9.79 percent on Wednesday.
    Social Reality Inc (NASDAQ: SRAX) shares rose 23.1 percent to $7.16 in the pre-market trading session after surging 37.59 percent on Wednesday.
    China Auto Logistics Inc (NASDAQ: CALA) rose 16.9 percent to $4.15 in pre-market trading after gaining 4.11 percent on Wednesday.
    Riot Blockchain Inc (NASDAQ: RIOT) rose 15.1 percent to $18.40 in pre-market trading after climbing 42.01 percent on Wednesday.
    Seven Stars Cloud Group Inc (NASDAQ: SSC) rose 14.5 percent to $2.85 in the pre-market trading session after gaining 0.40 percent on Wednesday.
    Affimed NV (NASDAQ: AFMD) shares rose 14.3 percent to $2.40 in pre-market trading after gaining 4.88 percent on Wednesday.
    Corecivic Inc (NYSE: CXW) rose 10.2 percent to $25.56 in pre-market trading after climbing 0.65 percent on Wednesday.
    LM Funding America, Inc. (NASDAQ: LMFA) rose 9.6 percent to $3.30 in pre-market trading after surging 34.98 percent on Wednesday.
    U.S. Global Investors, Inc. (NASDAQ: GROW) rose 7.2 percent to $3.30 in pre-market trading after dropping 8.06 percent on Wednesday.
    Xunlei Ltd (NASDAQ: XNET) rose 6.8 percent to $25.61 in pre-market trading after climbing 11.74 percent on Wednesday.
    Net 1 UEPS Technologies Inc (NASDAQ: UEPS) shares rose 5.9 percent to $13.00 in pre-market trading after gaining 21.34 percent on Wednesday.
    Addus Homecare Corporation (NASDAQ: ADUS) rose 5.5 percent to $35.60 in pre-market trading after gaining 3.69 percent on Wednesday.
    TOP SHIPS Inc (NASDAQ: TOPS) rose 5.2 percent to $0.528 in pre-market trading after falling 10.36 percent on Wednesday.
    Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) rose 4.7 percent to $14.11 in pre-market trading. Teva Pharma
  • [By Lisa Levin]

    Shares of Affimed NV (NASDAQ: AFMD) were down around 21 percent to $1.70. Affimed priced its public offering of 10,000,000 of its common shares at $1.80 per common share.

Top 10 Medical Stocks To Watch For 2018: Geopark Ltd(GPRK)

Advisors’ Opinion:

  • [By Dustin Parrett]

    As a service to our readers, we’ve put together a list of 10 cheap oil stocks under $5. Here are the stocks, share prices, and year-to-date (YTD) returns for each:

    Vallourec Sp (OTCMKTS ADR: VLOWY); $1.42; +13.6% YTDIthaca Energy Inc. (TSE: IAE); $1.93; +14.5% YTDSandRidge Permian Trust (NYSE: PER); $3.45; +16.95% YTDGeopark Ltd. (NYSE: GPRK); $5.06; +17.4% YTDGastar Exploration Inc. (NYSEMKT: GST); $1.89; +22.26% YTDAscent Resources Plc. (LON: AST); $2.11; +25.53% YTDErin Energy Corp. (NYSEMKT: ERN); $3.94; +29.1% YTDChesapeake Granite Wash Trust (NYSE: CHKR); $3.25; +38.3% YTDSouthcross Energy Partners LP (NYSE: SXE); $2.27; +68.15% YTDBonanza Creek Energy Inc. (NYSE: BCEI); $2.27; +122.55% YTD

    This list of oil stocks contains some highly speculative plays, so we can’t recommend buying them.